Brief: Iradimed Withdraws 2020 Financial Guidance Due To Uncertainties From The Effects Of Covid-19
April 7 (Reuters) - IRadimed Corp IRMD.O :
* ORATION WITHDRAWS 2020 FINANCIAL GUIDANCE DUE TO
UNCERTAINTIES
FROM THE EFFECTS OF COVID-19
* SEES Q1 2020 REVENUE $8.6 MILLION TO $8.7 MILLION
* AS OF MARCH 31, 2020, COMPANY EXPECTS TO REPORT CASH AND
CASH
EQUIVALENTS OF APPROXIMATELY $45.2 MILLION
Source text for Eikon: ID:nGNXbjVHSj
Further company coverage: IRMD.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on IRADIMED
See all newsIRadimed Corp reports results for the quarter ended June 30 - Earnings Summary
IRadimed Q2 profit rises on record monitor bookings
IRadimed Q1 revenue rises 13% on new product launch
IRadimed's Q4 revenue and EPS rise, declares higher dividend
MRI-compatible device maker IRadimed tops Q3 revenue estimates, raises guidance